Concepedia

Imogen Caird

IC

Statistics

Publications

4

Citations

133

H-Index

4

Active since

2019

Affiliations

Cornell University(Current)

Memorial Sloan Kettering Cancer Center

Imogen Caird is an author at Cornell University specializing in endometrial cancer, medicine, and oncology.

Publications per year

2019–2022

4

Publications

4

Phase 2 study of LY3023414 in patients with advanced endometrial cancer harboring activating mutations in the PI3K pathway

Maria M. Rubinstein, David M. Hyman, Imogen Caird et al. · Cancer · 2019 · 71 citations · Full text

, , +15

A phase II trial of durvalumab with or without tremelimumab in patients with persistent or recurrent endometrial carcinoma and endometrial carcinosarcoma.

Maria M. Rubinstein, Imogen Caird, Qin Zhou et al. · Journal of Clinical Oncology · 2019 · 25 citations

, , +17

Durvalumab with or without tremelimumab in patients with persistent or recurrent endometrial cancer or endometrial carcinosarcoma: A randomized open-label phase 2 study

Maria M. Rubinstein, Eric Rios Doria, Jason Konner et al. · Gynecologic Oncology · 2022 · 22 citations · Full text

, , +11

A phase I open-label study of selinexor with paclitaxel and carboplatin in patients with advanced ovarian or endometrial cancers

Maria M. Rubinstein, Rachel N. Grisham, Karen A. Cadoo et al. · Gynecologic Oncology · 2020 · 15 citations · Full text

, , +12

1–4 of 4